Lung Cancer Europe (LuCE) is the largest umbrella lung cancer advocacy group in Europe. Our members encompass advocacy groups and individuals spread across all of Europe.

As the voice of Europeans impacted by lung cancer, we come together to have a stronger collective voice advocating for lung cancer across Europe. We empower our members to ensure strong and effective lung cancer patient advocacy throughout Europe. We also collaborate with members and other stakeholders to destigmatise the disease and ensure that those impacted by lung cancer receive the care they need to achieve the best possible outcomes.

Our goal is for all Europeans impacted by lung cancer to have equity in access to optimal care, ensuring the best possible outcomes and quality of life. This includes people with the disease, their families, and caregivers. We spread the message encouraging people to get checked because anyone with lungs can get lung cancer.

Learn More


If you are a Lung Cancer Advocate, learn more about advocacy issues, news, and events relevant to you.

If you are living with lung cancer, learn more about the disease and what resources are available to you.

If you are a LuCE Member, learn more about the resources and tools available to you.

If you are a LuCE Supporter, learn more about the projects and initiatives being led by LuCE, and access resources relevant to you.


  • BMS Press Release is out now


    European Medicines Agency Validates Bristol Myers Squibb’s Application for Repotrectinib for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer and NTRK-Positive…

    Read More

  • Press Release: High risk of financial vulnerability after diagnosis: The majority of people impacted by lung cancer experience higher costs and reduction in income


    High risk of financial vulnerability after diagnosis:  The majority of people impacted by lung cancer experience higher costs and reduction in income Financial impact of lung…

    Read More

  • 8th Edition of the LuCE Report – Financial impact of lung cancer: A European perspective


    This is an annual initiative led by lung cancer patient organisations, across Europe with the purpose of raising awareness relating to the main challenges faced…

    Read More

  • 8th LuCE Report on Lung Cancer: Launch Event


    Join us at our launch of the 8th LuCE report: “Financial impact on lung cancer: A European Perspective”

    Read More

  • LuCE attending the European Medicines Agency (EMA) in Amsterdam


    November 14th – 15th in Amsterdam We are delighted to announce that Lung Cancer Europe (LuCE) is participating in a two-day meeting at the European Medicines Agency…

    Read More

  • Remembering Marjo Forsblom


    We are very sad to share the heartbreaking news that Marjo Forsblom passed away on Sunday October 22nd 2023. Marjo was a beautiful shining light…

    Read More

  • Highlights of ESMO Congress 2023


    LuCE present at the ESMO Congress 2023 October 20th-24th in Madrid, Spain Our president Anne-Marie Baird had an active participation at the ESMO Congress as…

    Read More

  • Introducing our newest Member: Lungunion Austria


    About the Organization Lungunion Austria  The Lungunion Austria is a patient organization (NGO and self-aid organization) for people with airway diseases, aligned skin diseases, and…

    Read More

  • Best Advocacy Initiative: Athena.Women Against Cancer


    During our Members Meeting 2023, 11 members presented their advocacy initiatives where they shared their goals, projects and accomplishments. With an overwhelming number of votes,…

    Read More


Social Media Feed